Your browser doesn't support javascript.
loading
Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients.
Wong, S Q; Fellowes, A; Doig, K; Ellul, J; Bosma, T J; Irwin, D; Vedururu, R; Tan, A Y-C; Weiss, J; Chan, K S; Lucas, M; Thomas, D M; Dobrovic, A; Parisot, J P; Fox, S B.
Afiliação
  • Wong SQ; 1] Department of Pathology, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia [2] Division of Cancer Research, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia.
  • Fellowes A; Department of Pathology, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.
  • Doig K; 1] Division of Cancer Research, Department of Bioinformatics, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia [2] Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria 3010, Australia.
  • Ellul J; Division of Cancer Research, Department of Bioinformatics, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.
  • Bosma TJ; Department of Pathology, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.
  • Irwin D; Agena Bioscience, Herston, Brisbane 4006, Australia.
  • Vedururu R; Department of Pathology, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.
  • Tan AY; Department of Pathology, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.
  • Weiss J; Translational Genomics and Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, The Olivia Newton-John Cancer and Wellness Centre, Heidelberg, Victoria 3084, Australia.
  • Chan KS; Department of Pathology, Singapore General Hospital, Singapore 169608, Singapore.
  • Lucas M; Clinical Informatics and Data Management Unit, Alfred Centre, Monash University, Melbourne, Victoria 3004, Australia.
  • Thomas DM; 1] Division of Cancer Research, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia [2] Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria 3010, Australia [3] The Kinghorn Cancer Centre, Garvan Institute of Medical Resea
  • Dobrovic A; 1] Department of Pathology, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia [2] Division of Cancer Research, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia [3] Translational Genomics and Epigenomics Laboratory, Olivia Newton-John Can
  • Parisot JP; 1] Division of Cancer Research, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia [2] Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria 3010, Australia.
  • Fox SB; 1] Department of Pathology, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia [2] Division of Cancer Research, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia [3] Sir Peter MacCallum Department of Oncology, The University of Melbourne,
Br J Cancer ; 112(8): 1411-20, 2015 Apr 14.
Article em En | MEDLINE | ID: mdl-25742471

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Análise Mutacional de DNA / Sequenciamento de Nucleotídeos em Larga Escala / Proteínas de Neoplasias / Neoplasias Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Análise Mutacional de DNA / Sequenciamento de Nucleotídeos em Larga Escala / Proteínas de Neoplasias / Neoplasias Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article